284 related articles for article (PubMed ID: 9345229)
1. The Nicholas Andry Award-1996. The molecular pathology of osteogenesis imperfecta.
Cole WG
Clin Orthop Relat Res; 1997 Oct; (343):235-48. PubMed ID: 9345229
[TBL] [Abstract][Full Text] [Related]
2. Osteogenesis imperfecta: phenotypic heterogeneity, protein suicide, short and long collagen.
Prockop DJ
Am J Hum Genet; 1984 May; 36(3):499-505. PubMed ID: 6375355
[No Abstract] [Full Text] [Related]
3. [Biochemical defects in hereditary diseases of the connective tissue (review)].
Del'vig AA
Vopr Med Khim; 1986; 32(2):2-14. PubMed ID: 3518233
[No Abstract] [Full Text] [Related]
4. [Collagen metabolic disorders--Ehlers-Danlos syndrome and osteogenesis imperfecta].
Nagai Y
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):801-4. PubMed ID: 3270895
[No Abstract] [Full Text] [Related]
5. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
6. Multiexon deletions in the type I collagen COL1A2 gene in osteogenesis imperfecta type IB. Molecules containing the shortened alpha2(I) chains show differential incorporation into the bone and skin extracellular matrix.
Mundlos S; Chan D; Weng YM; Sillence DO; Cole WG; Bateman JF
J Biol Chem; 1996 Aug; 271(35):21068-74. PubMed ID: 8702873
[TBL] [Abstract][Full Text] [Related]
7. Partial COL1A2 gene duplication produces features of osteogenesis imperfecta and Ehlers-Danlos syndrome type VII.
Raff ML; Craigen WJ; Smith LT; Keene DR; Byers PH
Hum Genet; 2000 Jan; 106(1):19-28. PubMed ID: 10982177
[TBL] [Abstract][Full Text] [Related]
8. Osteogenesis imperfecta phenotypes resulting from serine for glycine substitutions in the alpha2(I) collagen chain.
Nuytinck L; Wettinck K; Freund M; Van Maldergem L; Fabry G; De Paepe A
Eur J Hum Genet; 1997; 5(3):161-7. PubMed ID: 9272740
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum-mediated quality control of type I collagen production by cells from osteogenesis imperfecta patients with mutations in the pro alpha 1 (I) chain carboxyl-terminal propeptide which impair subunit assembly.
Lamandé SR; Chessler SD; Golub SB; Byers PH; Chan D; Cole WG; Sillence DO; Bateman JF
J Biol Chem; 1995 Apr; 270(15):8642-9. PubMed ID: 7721766
[TBL] [Abstract][Full Text] [Related]
10. Defects in the processing of procollagen to collagen are demonstrable in cultured fibroblasts from patients with the Ehlers-Danlos and osteogenesis imperfecta syndromes.
Minor RR; Sippola-Thiele M; McKeon J; Berger J; Prockop DJ
J Biol Chem; 1986 Jul; 261(21):10006-14. PubMed ID: 3733683
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene of type I collagen. The mosaic parent exhibits phenotypic features of a mild form of the disease.
Edwards MJ; Wenstrup RJ; Byers PH; Cohn DH
Hum Mutat; 1992; 1(1):47-54. PubMed ID: 1301191
[TBL] [Abstract][Full Text] [Related]
12. Type I procollagen in the severe non-lethal form of osteogenesis imperfecta. Defective pro-alpha 1(I) chains in a patient with abnormal proteoglycan metabolism and mineral deposits in the dermis.
Tenni R; Cetta G; Dyne K; Rossi A; Quacci D; Lenzi L; Castellani AA
Hum Genet; 1988 Jul; 79(3):245-50. PubMed ID: 3402997
[TBL] [Abstract][Full Text] [Related]
13. The clinical features of homozygous alpha 2(I) collagen deficient osteogenesis imperfecta.
Nicholls AC; Osse G; Schloon HG; Lenard HG; Deak S; Myers JC; Prockop DJ; Weigel WR; Fryer P; Pope FM
J Med Genet; 1984 Aug; 21(4):257-62. PubMed ID: 6492090
[TBL] [Abstract][Full Text] [Related]
14. The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrix.
Cole WG; Chow CW; Bateman JF; Sillence DO
J Med Genet; 1996 Nov; 33(11):965-7. PubMed ID: 8950680
[TBL] [Abstract][Full Text] [Related]
15. Substitution of an aspartic acid for glycine 700 in the alpha 2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone.
Cohen-Solal L; Zylberberg L; Sangalli A; Gomez Lira M; Mottes M
J Biol Chem; 1994 May; 269(20):14751-8. PubMed ID: 8182080
[TBL] [Abstract][Full Text] [Related]
16. Mutations near amino end of alpha1(I) collagen cause combined osteogenesis imperfecta/Ehlers-Danlos syndrome by interference with N-propeptide processing.
Cabral WA; Makareeva E; Colige A; Letocha AD; Ty JM; Yeowell HN; Pals G; Leikin S; Marini JC
J Biol Chem; 2005 May; 280(19):19259-69. PubMed ID: 15728585
[TBL] [Abstract][Full Text] [Related]
17. An in vitro model to evaluate the properties of matrices produced by fibroblasts from osteogenesis imperfecta and Ehlers-Danlos Syndrome patients.
Micha D; Pals G; Smit TH; Ghazanfari S
Biochem Biophys Res Commun; 2020 Jan; 521(2):310-317. PubMed ID: 31668813
[TBL] [Abstract][Full Text] [Related]
18. Deposition of mutant type I collagen in the extracellular matrix of cultured dermal fibroblasts in osteogenesis imperfecta.
Cetta G; Rossi A; Tenni R; Valli M; Forlino A; Zanaboni G; Dyne K; Burgio GR
Connect Tissue Res; 1993; 29(1):41-9. PubMed ID: 8339545
[TBL] [Abstract][Full Text] [Related]
19. Abnormal procollagen synthesis in fibroblasts from three patients of the same family with a severe form of osteogenesis imperfecta (type III).
Bonaventure J; Cohen-Solal L; Lasselin C; Allain JC; Maroteaux P
Biochim Biophys Acta; 1986 Oct; 889(1):23-34. PubMed ID: 3768427
[TBL] [Abstract][Full Text] [Related]
20. Serine for glycine substitutions in the C-terminal third of the alpha 1(I) chain of collagen I in five patients with nonlethal osteogenesis imperfecta.
Lund AM; Skovby F; Schwartz M
Hum Mutat; 1997; 9(4):378-82. PubMed ID: 9101304
[No Abstract] [Full Text] [Related]
[Next] [New Search]
